A MULTICENTER, OBSERVATIONAL POST-MARKET CLINICAL FOLLOW-UP STUDY IN PATIENTS WITH RA, PsA, OR axSpA ASSESSING THE PATIENT EXPERIENCE WITH THE CIMZIA AVA DEVICE OR OTHER TNF-BLOCKER AUTO-INJECTOR DEVICES First published 03/12/2019 Last updated 02/07/2024 EU PAS number:EUPAS32246 Study Finalised